LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
about
The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activityLRRK2 transport is regulated by its novel interacting partner Rab32An early endosome regulator, Rab5b, is an LRRK2 kinase substrateTherapeutic and diagnostic challenges for frontotemporal dementiaProgressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in micePhosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPasesAlpha-synuclein and tau: teammates in neurodegeneration?Gene and MicroRNA transcriptome analysis of Parkinson's related LRRK2 mouse modelsA visual review of the interactome of LRRK2: Using deep-curated molecular interaction data to represent biology.Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expressionBack to the tubule: microtubule dynamics in Parkinson's disease.Protein phosphorylation in neurodegeneration: friend or foe?LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesisInteraction of LRRK2 with kinase and GTPase signaling cascadesCellular processes associated with LRRK2 function and dysfunctionThe Role of α-Synuclein and LRRK2 in Tau Phosphorylation.LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?LRRK2 at the Crossroad Between Autophagy and Microtubule Trafficking: Insights into Parkinson's Disease.Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic miceMechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation.Physiologically relevant factors influence tau phosphorylation by leucine-rich repeat kinase 2.LRRK2 Promotes Tau Accumulation, Aggregation and Release.Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation.Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice.LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory.Genetic dissection reveals that Akt is the critical kinase downstream of LRRK2 to phosphorylate and inhibit FOXO1, and promotes neuron survival.Tauopathies: Mechanisms and Therapeutic Strategies.G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain.Clinical and neuropathological features of progressive supranuclear palsy in Leucine rich repeat kinase (LRRK2) G2019S mutation carriers.Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy PathologyDesigning antibodies against LRRK2-targeted tau epitopes
P2860
Q24293505-024560C2-F31E-4E55-BF8B-473277E52D46Q24306357-7F6E627A-B932-4472-B651-13AA33AD67E8Q24315778-2CC8481B-2336-43DE-BE91-7B9AEFC78A79Q26998919-FC866B46-C389-460D-BE18-0E520D2F83ABQ27308060-CE573B7E-2BB3-4DB2-B6A1-200E64666EA5Q28119192-68E9AB33-2AA9-4152-9254-5E71556191C9Q28250508-C9877343-FF8D-465D-802D-04A887F745D9Q28589606-93498E4E-6D50-4F7B-99BD-9C85DB26C77CQ30887351-1A73A1C4-6833-418C-9805-901AE4339E6EQ34481921-C983E644-B6F8-4857-B9DE-05E6A19198E0Q35423634-F6C73CEE-01C4-4AFC-8EBC-C4B9469C5FB9Q36073860-BA412A84-EB3C-4E0E-A3F8-F6487CA05FC0Q37590635-4CB51CA9-9295-44C2-984D-A5C262CE33CAQ38214594-68AE2A04-F53C-4B48-8ED8-448E60CA3D7CQ38218398-8AB9B890-EB47-49EE-8A55-257DA9223B08Q38234885-374F6E4C-A76C-470A-9802-5E65B1CF0503Q38433725-024E3397-2A34-4544-AE1C-6F7ED9D0CF91Q38482479-25B11C30-84E0-4BD1-99F7-F6FEAB8CC71CQ38620229-41A46CFF-6F65-42A7-B936-A71DC4612A65Q38689010-794589F8-F4A9-4AC7-97E4-831E441F28AEQ38795375-4F0794D0-DD16-47E9-B99F-E500D154CEE7Q39137358-40678490-9049-4DBF-B4B9-94C41145E754Q40784600-B75CADF6-CD65-470A-9744-6F6B305BDF4DQ40899192-32D0C5A7-4E45-41CC-BC41-110FC7E24B41Q41791628-51FAA12E-FDE4-405C-99C6-B2E78EDB4305Q41978493-D2A6C75E-7F3A-4877-AC2E-AA9970CC1D23Q42467623-6BC28B9F-5195-4672-9F85-C9AEE88CD50EQ47071359-348CA63E-F8F4-476F-B379-9157C8767880Q47253592-D4EA387E-33E2-4347-AC72-FFE75D77F956Q47582501-B2E83D87-C654-43D0-854E-6D3BF993EB03Q47978229-49219D35-93F6-4024-9232-F2716BD1B472Q56504087-4FBC66C7-7BCE-4ED5-B3A0-2B82C174F473Q58691694-95CC94C2-DD13-4611-9DF5-A8AE13DBDD46
P2860
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@ast
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@en
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@en-gb
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@nl
type
label
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@ast
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@en
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@en-gb
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@nl
prefLabel
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@ast
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@en
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@en-gb
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@nl
P2093
P2860
P50
P1476
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
@en
P2093
Benoit I Giasson
Heather L Melrose
Jada Lewis
Jason P Covy
Joshua Knight
Linda Rousseau
Rachel M Bailey
Sarah Miles
P2860
P2888
P304
P356
10.1007/S00401-013-1188-4
P407
P577
2013-12-01T00:00:00Z
P5875
P6179
1013850625